FDA's Testosterone Label Changes: Implications and Unresolved Issues.

FDA updates to testosterone product labeling may influence prescribing practices but leave unresolved issues in clinical management.

• Why it matters: Understanding the implications of regulatory label changes is crucial for safe and effective testosterone therapy, especially given ongoing debates about its risks and benefits.
• What they did: The authors review recent FDA label modifications for testosterone products and analyze their potential impact on clinical decision-making and patient safety.
• The result: The perspective highlights that while label updates aim to improve prescribing clarity, several unresolved issues remain that require further investigation and guidance.